Invalid Symbol

Stock Research for PDII

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


PDII Stock Chart & Research Data

The PDII chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PDII chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PDII Due diligence Resources & Stock Charts

The PDII stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PDII Detailed Price Forecast - CNN Money CNN View PDII Detailed Summary - Google Finance
Yahoo View PDII Detailed Summary - Yahoo! Finance Zacks View PDII Stock Research & Analysis -

Stock Analysis

TradeIdeas View PDII Trends & Analysis - Trade-Ideas Barrons View PDII Major Holders - Barrons
NASDAQ View PDII Call Transcripts - NASDAQ Seeking View PDII Breaking News & Analysis - Seeking Alpha
Spotlight View PDII Annual Report - OTC Report View PDII OTC Short Report -
TradeKing View PDII Fundamentals - TradeKing Charts View PDII SEC Filings - Bar Chart
WSJ View Historical Prices for PDII - The WSJ Morningstar View Performance/Total Return for PDII - Morningstar
MarketWatch View the Analyst Estimates for PDII - MarketWatch CNBC View the Earnings History for PDII - CNBC
StockMarketWatch View the PDII Earnings - StockMarketWatch MacroAxis View PDII Buy or Sell Recommendations - MacroAxis
Bullish View the PDII Bullish Patterns - American Bulls Short Pains View PDII Short Pain Metrics -

Social Media Mentions

StockTwits View PDII Stock Mentions - StockTwits PennyStocks View PDII Stock Mentions - PennyStockTweets
Twitter View PDII Stock Mentions - Twitter Invest Hub View PDII Investment Forum News - Investor Hub
Yahoo View PDII Stock Mentions - Yahoo! Message Board Seeking Alpha View PDII Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PDII - Insider Cow View Insider Transactions for PDII - Insider Cow
CNBC View PDII Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PDII - OTC Markets
Yahoo View Insider Transactions for PDII - Yahoo! Finance NASDAQ View Institutional Holdings for PDII - NASDAQ

Stock Charts

FinViz View PDII Stock Insight & Charts - StockCharts View PDII Investment Charts -
BarChart View PDII Stock Overview & Charts - BarChart Trading View View PDII User Generated Charts - Trading View

Latest Financial News for PDII

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Interpace Diagnostics Group's (IDXG) CEO Jack Stover on Q3 2017 Results ...
Seeking Alpha - Nov 13, 2017
Good morning everyone. Thank you for joining us for the Interpace Diagnostics Conference Call to review the company's financial results and operations for the third quarter and year-to-date ended September 30, 2017, as well as recent developments. The ...

Interpace Diagnostics Recognized as One of the Top 20 Bioinformatics Solutions ...
GlobeNewswire (press release) - Jan 8, 2018
PARSIPPANY, N.J., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or the “Company”), a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and ...

Interpace Diagnostics Announces Increased Reimbursement for ThyGenX®
GlobeNewswire (press release) - Oct 11, 2017
Overall, Medicare represents approximately 40% of the Company's volume for the ThyGenX test; given the Company's recent announcements of coverage for ThyGenX among numerous commercial health plans, the overall payer mix for the remainder of the volume ...

Interpace Diagnostics Group Inc (IDXG) PT Lowered to $3 at Maxim Group - Feb 14, 2018
Maxim Group lowered its price target on Interpace Diagnostics Group Inc (NASDAQ: IDXG) to $3.00 (from $5.00) while maintaining a Buy rating.
At $0.9749, Is It Time To Buy Interpace Diagnostics Group Inc (NASDAQ:IDXG)? - Simply Wall St
Now Offering Discount Or Premium? – Puma Biotechnology, Inc. (PBYI), Interpace ... - Post Analyst

Enter a stock symbol to view the stock details.